Concepedia

Publication | Open Access

Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer

77

Citations

38

References

2014

Year

References

YearCitations

Page 1